GH — Guardant Health Balance Sheet
0.000.00%
- $8.16bn
- $8.65bn
- $739.02m
- 43
- 23
- 87
- 49
Annual balance sheet for Guardant Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,795 | 933 | 1,011 | 1,169 | 840 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.3 | 97.7 | 97.3 | 88.8 | 110 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1,888 | 1,114 | 1,192 | 1,347 | 1,055 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 100 | 314 | 342 | 303 | 279 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,272 | 2,204 | 1,610 | 1,786 | 1,486 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 66.8 | 195 | 193 | 206 | 226 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 973 | 1,559 | 1,550 | 1,628 | 1,625 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,298 | 645 | 60.2 | 159 | -140 |
| Total Liabilities & Shareholders' Equity | 2,272 | 2,204 | 1,610 | 1,786 | 1,486 |
| Total Common Shares Outstanding |